Navigation Links
Shortages of Potassium Iodide as Radiation Panic Drives Demand

DENVER, March 28, 2011 /PRNewswire/ -- The Japanese nuclear crisis has caused a surge in the demand of potassium iodide, causing shortages not only in Japan, but as far away as California, western Canada, and even southeastern Russia. Although potassium iodide does not provide generalized radiation protection because it only shields the thyroid, manufacturers and pharmacies are being bombarded with orders as the radiation hysteria mounts.

A new and superior product, known as the BioShield Radiation Pill, could restore calm to worried residents in affected areas. Scientists at Premier Micronutrient Corporation have developed this pill as the first ever that is proven to protect DNA from damage caused by radiation. The product was originally developed at the request of the Marine Corps after 9/11 to protect military personnel from the adverse effects of radiation they might encounter while fighting in the Middle East. Research conducted with the Department of Defense, NASA, and prominent universities has demonstrated effectiveness in addressing radiation-induced oxidative stress.

Dr. James Ehrlich was on the team that developed this groundbreaking pill. Invite this engaging and knowledgeable guest to answer:

  • Should all residents near nuclear plants have the BioShield pill in case of a radiation emergency?
  • Is this pill safe for young children?
  • How does the BioShield pill work differently from potassium iodide?
  • How long after exposure can this pill provide protective benefits?
  • Is this pill available without a prescription?

CREDENTIALS: Dr. James Ehrlich is a Clinical Associate Professor at the University of Colorado and an Adjunct Assistant Professor in the department of medicine at the George Washington University Medical Center. He is the medical director of Early Detection Technologies, LLC, which advises on best practices involving biomarkers, imaging technologies, and radiation protection. Involved in atherosclerosis research at two medical schools, Dr. Ehrlich is a founding member of the Society of Atherosclerosis Imaging, a co-founder of the Society of Cardiovascular CT, and he created the Society for Responsible Preventive Imaging. He is head of the medical advisory board of U.S. Preventive Medicine and is on the board of Premier Micronutrient Corporation with a particular focus on biologic radiation protection. Dr. Ehrlich is a co-author of a multimedia CD called The Physician's Guide to Coronary Imaging. He has appeared on over 200 TV and radio programs nationwide.

CONTACT: James Ehrlich, M.D., (303) 808-6470 (CO);; and

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE Premier Micronutrient Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Study Shows Nu-Tek's Modified Potassium Chloride Improves Yields in Meat Processing
2. 50,000 Potassium Iodide Pills Donated to Japan
3. Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials
4. New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric
5. Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury
6. Trinitas Comprehensive Cancer Center Now Offering Cancer Patients Faster, Ultra-Precise Radiation Using New RapidArc Technology
7. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
8. Oncolytics Biotech(R) Inc. Announces Positive Results of U.K. Phase II REOLYSIN(R) and Radiation Combination Clinical Trial
9. New near-field radiation therapy promises relief for overheating laptops
10. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
11. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
Post Your Comments:
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
(Date:11/24/2015)... -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting ... Israel time, at the law offices of ... th Floor, Tel Aviv, Israel . ... Izhak Tamir to the Board of Directors; , election of ... approval of an amendment to certain terms of options granted to our ...
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Twist ... announced that Emily Leproust, Ph.D., Twist Bioscience chief ... Jaffray Healthcare Conference on December 1, 2015 at ... Hotel in New York City. --> ... . Twist Bioscience is on Twitter. ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
Breaking Biology Technology:
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/26/2015)... 26, 2015 ... adds Biometrics Market Shares, Strategies ... well as Emerging Biometrics Technologies: Global ... its collection of IT and Telecommunications ... --> . ...
(Date:10/26/2015)... , Oct. 26, 2015  Delta ID Inc., ... authentication to mobile and PC devices, announced its ActiveIRIS® ... the arrows NX F-02H launched by NTT DOCOMO, INC ... F-02H is the second smartphone to include iris recognition ... in ARROWS NX F-04G in May 2015, world,s first ...
Breaking Biology News(10 mins):